Data / Form D filings / Orpheus Bioscience, Inc.
Orpheus Bioscience, Inc.: Form D filings
Orpheus Bioscience, Inc., a company in Manassas, VA, filed 4 Form D notices with the SEC between 2017 and 2019. The latest, on June 25, 2019, reports $3.2 million sold of a $5 million offering to 38 investors.
Find out what Orpheus Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9385 DISCOVERY BLVD. #115, Manassas, VA, 20109
- Phone
- (212) 692-6758
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1707212
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2019 | New notice | $5,000,550 | $3,157,125 | $1,843,425 | 38 | Jun 11, 2019 | sec.gov |
| Jul 6, 2017 | Amendment | $1,600,000 | $1,255,000 | $345,000 | 20 | May 23, 2017 | sec.gov |
| Jun 7, 2017 | Amendment | $1,600,000 | $1,255,000 | $345,000 | 20 | May 23, 2017 | sec.gov |
| May 22, 2017 | New notice | $1,600,000 | $1,455,000 | $145,000 | 20 | May 9, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cohava Gelber | Director | |
| Guy Yachin | Executive Officer, Director | |
| John Abeles | Director |
Other companies in Virginia that filed recently
- Duck Island Project LLC offering · Nov 6, 2026
- Intalus, Inc. offering · Nov 3, 2026
- MIAMI VICE AXXES CAPITAL LLC $3.9 million · Nov 2, 2026
- MIAMI VICE 29 TERRACE LLC $5 million · Nov 2, 2026
- MIAMI VICE VENUS LLC $5.1 million · Nov 2, 2026
- Amadoras del Vino Investors, LLC offering · Nov 2, 2026
- GEM Ventures LLC $630,000 · Oct 21, 2026
- Tuckahoe Holdings, LLC offering · Oct 16, 2026
- Air Control Concepts Management Holdings, LLC $2 million · Oct 15, 2026
- Air Control Concepts Holdings, L.P. $3.5 million · Oct 15, 2026
- Octaris Technologies Inc. offering · Oct 14, 2026
- GP Defense Investments, LLC $5.9 million · Oct 9, 2026
- Play Your Court, LLC $120,000 · Oct 1, 2026
- Champions League of American Wrestling, LLC $150,000 · Sep 30, 2026
- Greenwave Technology Solutions, Inc. $3.8 million · Sep 24, 2026
Every Form D from the week of Jun 24, 2019 · All recent filings in Virginia · All recent Other filings
Read from SEC EDGAR. Amount sold is what Orpheus Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.